brintellix 20 mg
lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 20 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.
brintellix 5 mg
lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.
brintellix 5 mg
lundbeck israel ltd. - vortioxetine as hydrobromide - film coated tablets - vortioxetine as hydrobromide 5 mg - vortioxetine - brintellix is indicated for the treatment of major depressive episodes in adults.
mirataz
dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - cats - for bodyweight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions.
spravato solution
janssen inc - esketamine (esketamine hydrochloride) - solution - 28mg - esketamine (esketamine hydrochloride) 28mg - miscellaneous antidepressants
spravato
j-c health care ltd - esketamine as hydrochloride - solution for spray - esketamine as hydrochloride 28 mg/vial - esketamine - spravato, in combination with a ssri or snri, is indicated for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.spravato, co-administered with oral antidepressant therapy, is indicated in adults with a moderate to severe episode of major depressive disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency.limitations of use: the effectiveness of spravato in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. use of spravato does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of spravato.
spravato nasal spray 28mgvial
johnson & johnson international (singapore) pte ltd - esketamine hcl 32.2mg eqv. to esketamine - spray - esketamine hcl 32.2mg eqv. to esketamine 28mg/vial
agomaval 25 mg film-coated tablets
krka dd novo mesto novo mesto, Šmarješka cesta 6, 8501 novo mesto, slovenia - agomelatine - film-coated tablet - agomelatine 25 milligram(s) - psychoanaleptics
agomaval 25 mg film-coated tablets
tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - film-coated tablet - agomelatine 25 mg - psychoanaleptics
miln-avenir 25 mg
bioavenir ltd, israel - milnacipran as hydrochloride - capsules - milnacipran as hydrochloride 25 mg - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old